Home » Business, Health & Medicine, Pharmaceuticals & Biotech » Sales Scale Of Cardiovascular Drugs Market In China Will Reach About CNY 45 Billion By 2018: Radiant Insights Inc.
“Radiant Insights Inc.”
Radiant Insights has announced the addition of “Research on China Cardiovascular Drugs Industry, 2014-2018” Market Research report to their database

Research on China Cardiovascular Drugs Industry, 2014-2018 primarily carries on analyses on cardiovascular drugs market in the following aspects: market scale, the scale of segment markets, and current competition status and business performance of major drug manufacturers; meanwhile it makes predictions about prospective market so as to help investors know this industry well and provide decision-making references for them.  

To read full report, click here:
http://www.radiantinsights.com/research/research-on-china-cardiovascular-drugs-industry-2014-2018

With the aged tendency of population in China and the increasing morbidity of chronic diseases which have to be treated with medicines for the rest of patients’ life, market scale of cardiovascular drugs is expanding. This trend has been reflected in recent years. While in the next few years, with the reform of medical insurance in China and the continuous standardization of pharmaceutical market as well as the unique curative effect of Chinese patent medicines, Chinese patents medicines for cardiovascular diseases will enjoy a promising development prospect.

See More Reports of This Category by Radiant Insights:
http://www.radiantinsights.com/catalog/pharmaceuticals-and-healthcare

In 2013 market scale of cardiovascular drugs has reached CNY 17.8 billion in China. At present cardiovascular diseases have a relatively higher morbidity rate among all diseases and also is a kind of disease that is hard to be cured. Along with the changes of people’s life-styles, the difficulties in curing cardiovascular diseases are becoming more prominent. The compound annual growth rate of cardiovascular diseases is 21.6%, and the prevalence rate of cardiovascular diseases will increase further because of the improvements on people’s living standards, the changes of life styles and increasing aging population. The market will be expanded.

Related reports by Radiant Insights:

Research and Forecast of China Smart Water Meter Industry, 2014-2018:
http://www.radiantinsights.com/research/research-and-forecast-of-china-smart-water-meter-industry-2014-2018    

Smart water meter is a new type of water meter integrating modern microelectronic techniques, modern sensor technology and other advanced technologies, which is used for metering water consumption, transferring data and clearing trade transaction. 

Research and Future Trend of China Baby Food Industry (excluding milk formula), 2014-2018:
http://www.radiantinsights.com/research/research-and-future-trend-of-china-baby-food-industry-excluding-milk-formula-2014-2018        

Baby food in this report includes baby cereals, meals, cookies, etc, excluding milk formula. The report primarily conducts analyses on China baby food industry in the following aspects: domestic market status, supply and demand, competitive pattern, major enterprises both in China and overseas; meanwhile it offers suggestions, so as to make investors understand this industry well and provides decision-making references for them.

About Radiant Insights       

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

For more information, visit: http://www.radiantinsights.com/

Media Contact
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist – USA
Email: sales@radiantinsights.com
Phone: (415) 349-0054, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: Califonia
Country: United States
Website: http://www.radiantinsights.com/research/research-on-china-cardiovascular-drugs-industry-2014-2018

Comments are closed.